Germany – Pharmaceutical products – Abschluss eines nicht exklusiven Rabattvertrages nach § 130a Abs. 8 SGB V zu Arzneimitteln mit dem Wirkstoff Lanthan(III)-carbonat (ATC-Code: V03AE03).

Conclusion of a non-exclusive discount contract pursuant to Section 130a, paragraph 8, SGB V for medicinal products with the active substance Lanthanum(III) carbonate (ATC Code: V03AE03) within the period from 01.07.2026 to 30.06.2028 with the possibility of concluding the contract at any time during the contract period ("open-house model").